当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析 - 现金流量表

惠泰医疗

(688617)

  

流通市值:384.96亿  总市值:384.96亿
流通股本:1.42亿   总股本:1.42亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,723,974,082.781,775,061,401.12828,161,216.72,877,820,327.03
  收到的税费返还9,787,302.19,443,433.241,594,167.0212,095,630.09
  收到其他与经营活动有关的现金30,405,452.7619,553,678.2310,910,125.5984,968,721.39
  经营活动现金流入小计2,764,166,837.641,804,058,512.59840,665,509.312,974,884,678.51
  购买商品、接受劳务支付的现金528,264,529.33347,104,411.35140,287,811.71560,908,178.76
  支付给职工以及为职工支付的现金640,695,613.8460,112,873.1292,872,952.57652,711,882.34
  支付的各项税费347,387,694.54235,850,703.21110,594,955.6343,299,570.66
  支付其他与经营活动有关的现金299,598,636.62211,705,342.03104,712,847.91450,205,387.97
  经营活动现金流出小计1,815,946,474.291,254,773,329.69648,468,567.792,007,125,019.73
  经营活动产生的现金流量净额948,220,363.35549,285,182.9192,196,941.52967,759,658.78
二、投资活动产生的现金流量:
  收回投资收到的现金1,751,505,643.881,391,505,643.88506,505,643.852,515,428,765.89
  取得投资收益收到的现金4,698,435.594,069,564.561,760,068.527,542,413.5
  处置固定资产、无形资产和其他长期资产收回的现金净额1,076,341.91610,594.2955,600223,150
  投资活动现金流入小计1,757,280,421.381,396,185,802.73508,321,312.372,523,194,329.39
  购建固定资产、无形资产和其他长期资产支付的现金126,819,214.0188,656,661.9864,998,258.32285,589,236.87
  投资支付的现金1,992,500,0001,212,500,000547,500,0002,738,500,000
  支付其他与投资活动有关的现金---18,287,481.34
  投资活动现金流出小计2,119,319,214.011,301,156,661.98612,498,258.323,042,376,718.21
  投资活动产生的现金流量净额-362,038,792.6395,029,140.75-104,176,945.95-519,182,388.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金46,185,336.7246,185,336.72985,437.335,936,123.81
  取得借款收到的现金---4,000,000
  收到其他与筹资活动有关的现金15,500,0007,500,0005,000,00015,000,000
  筹资活动现金流入小计61,685,336.7253,685,336.725,985,437.354,936,123.81
  偿还债务支付的现金3,920,0003,920,0003,920,000671,000
  分配股利、利润或偿付利息支付的现金139,177,631139,177,6315,292170,270,015.69
  支付其他与筹资活动有关的现金457,860,812.55454,974,237.3352,734,401.2163,738,987.11
  筹资活动现金流出小计600,958,443.55598,071,868.3356,659,693.2334,680,002.8
  筹资活动产生的现金流量净额-539,273,106.83-544,386,531.58-350,674,255.9-279,743,878.99
四、汇率变动对现金及现金等价物的影响-20,210,357.87-15,865,417.01-6,876,599.69-3,790,697.36
五、现金及现金等价物净增加额26,698,106.0284,062,375.06-269,530,860.02165,042,693.61
  加:期初现金及现金等价物余额1,246,130,604.641,246,130,604.641,246,130,604.641,081,087,911.03
  期末现金及现金等价物余额1,272,828,710.661,330,192,979.7976,599,744.621,246,130,604.64
补充资料:
  净利润-527,858,916.19-807,739,206.52
  资产减值准备-6,091,104.74-6,547,893.55
  固定资产和投资性房地产折旧-54,067,184.63-95,407,662.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-54,067,184.63-95,407,662.28
  无形资产摊销-7,115,917.25-6,449,626.04
  长期待摊费用摊销-917,160.59-1,689,920.46
  处置固定资产、无形资产和其他长期资产的损失-336,235.71-926,856.07
  固定资产报废损失-6,909.05-1,856,221.03
  公允价值变动损失--587,824.69--485,745.67
  财务费用-15,546,021.87-6,756,280.51
  投资损失--19,514,195.06--16,938,228.6
  递延所得税-4,714,633.95--11,296,072.18
  其中:递延所得税资产减少-4,881,117.49--12,354,470.89
    递延所得税负债增加--166,483.54-1,058,398.71
  存货的减少--8,094,249.63--111,474,659.7
  经营性应收项目的减少--12,352,657.13--120,855,164.6
  经营性应付项目的增加--32,409,988.44-269,877,790.74
  其他-2,214,362.53-5,686,840.71
  现金的期末余额-1,330,192,979.7-1,246,130,604.64
  减:现金的期初余额-1,246,130,604.64-1,081,087,911.03
  现金及现金等价物的净增加额-84,062,375.06-165,042,693.61
公告日期2026-10-292026-08-202026-04-242026-03-25
审计意见(境内)标准无保留意见
TOP↑